Sort by
Refine Your Search
-
areas. These include, but are not limited to: Applying machine learning algorithms to solve real-world problems. Creating and structuring databases for storage, retrieval, and image analysis. Determining
-
pursues disruptive qubit research, innovative workforce development programs, and deep, collaborative partnerships to tackle some of the hardest open problems in quantum information science and technology
-
adverse events to inform standard ER analyses for safety and provide complementary tolerability data to improve dosage optimization strategies in oncology clinical trials. Learning Objectives: As an ORISE
-
, Environmental Sanitation and Hygiene, and Laboratory Services. What will I be doing? Under the guidance of an epidemiologist mentor, you will be involved with and learn how to: Collect, evaluate and provide
-
: Research activities will be conducted in BSL-2+ laboratories. Learning Objectives: Under the guidance of a mentor, the participant will gain experience in: Animal studies: mouse and large animal inoculation
-
students and collaborate on aquatic ecology field projects in southeast Alaska wilderness watersheds. Learning Objectives: Learn about bioenergetic food web models to quantify food web energy fluxes between
-
to join this development team as a fellow and learn to create, evaluate, and validate rapid, accurate, and sensitive diagnostic methods for detecting disease pathogens. The fellow will have an opportunity
-
, focusing on gene editing and molecular breeding techniques. While flowering in sugarcane is an undesirable trait for Florida farmers, it plays a crucial role in crossing and breeding. Through this learning
-
to support both premarket and postmarket safety evaluation. Learning Objectives: The fellowship will provide you with learning in regulatory data science through weekly mentored meetings and monthly steering
-
an enhanced user interface that incorporates various functionalities to support adverse event analysis. Learning Objectives: You will join generations of scientists in the field of pharmacoepidemiology